Summary: Researchers have generated more than 400 distinct human neuron types in vitro, greatly expanding the range of cells available for neuroscience research. By systematically combining targeted genetic programming with carefully varied morphogen signals, the team reproduced a richness of neuronal identities that better reflects the brain’s natural diversity.
This advance enables more precise disease models and drug testing that account for the specific neuronal subtypes involved in disorders. The next goal is to refine the protocols so each experiment yields a single, well-defined neuron type reliably.
Key facts:
- Unprecedented diversity: Over 400 neuron subtypes produced in vitro, capturing much of the brain’s complexity.
- Improved disease modeling: Enables more accurate cell-based models for neurological disorders and targeted pharmacological studies.
- Future work: Optimize conditions to generate single, pure neuron subtypes reproducibly.
Source: ETH Zurich
Nerve cells are not all the same. Modern estimates suggest the human brain contains several hundred to several thousand distinguishable neuron types, depending on how finely subtypes are defined. These types differ in their roles, shapes and sizes of cellular processes, connectivity, neurotransmitter profiles, and regional distribution across structures such as the cerebral cortex or midbrain.
Historically, producing neurons from stem cells in the laboratory did not capture this breadth of diversity. Existing methods typically yielded only a few dozen neuron subtypes. Researchers used either genetic programming—forcing expression of neuronal transcription factors—or the addition of signaling molecules to bias development, but neither approach alone reached the spectrum of neuron types present in humans.
“Neurons derived from stem cells are widely used to study disease, but the specific neuronal subtype is often overlooked,” says Barbara Treutlein, Professor at the Department of Biosystems Science and Engineering at ETH Zurich. “Accurate disease models require attention to the particular neuron types affected by conditions such as Alzheimer’s, Parkinson’s and depression.”
Systematic screening was the key to success
Treutlein and her colleagues achieved the production of more than 400 distinct neuron types by applying a systematic, high-throughput screening strategy. They started with human induced pluripotent stem cells (iPSCs) derived from blood cells, using genetic engineering to activate pro-neural regulator genes and exposing cells to different morphogens—signaling molecules that guide tissue patterning during development.
The team tested seven morphogens in multiple combinations and concentrations, creating nearly 200 different experimental conditions. This combinatorial design allowed them to map how specific morphogen environments, together with pro-neural transcription factors, direct cells toward particular neuronal identities.
Morphogens
Morphogens are signaling molecules known from embryonic development. They form concentration gradients that provide spatial information to cells, helping determine positional identity—whether a cell will become part of the head, torso, back, or a particular region within the nervous system. By mimicking these gradients in vitro, researchers can push stem cells toward regionally patterned neuronal fates.
To validate the diversity of the induced neurons, the researchers combined single-cell RNA sequencing—measuring gene expression at single-cell resolution—with morphological and electrophysiological analyses. They examined each cell’s gene activity, external appearance (including types and lengths of cellular processes), and functional properties such as firing patterns. Comparing these data to reference atlases of human neurons allowed the team to annotate many induced neuron (iN) subtypes, identifying cells related to peripheral nervous system types and neurons native to forebrain, midbrain, hindbrain and spinal cord regions, and distinguishing neurotransmitter classes like glutamatergic, GABAergic, dopaminergic and cholinergic neurons.
Applications for drug research and therapy
Although the researchers have not yet recreated every neuron type that exists in the human brain, the expanded catalogue represents a substantial step forward. Access to hundreds of well-characterized neuron subtypes makes it possible to build more faithful in vitro disease models for conditions such as schizophrenia, Alzheimer’s, Parkinson’s, epilepsy, sleep disorders and multiple sclerosis.
Such cell culture models are valuable for pharmaceutical testing because they can reveal subtype-specific drug responses without immediate reliance on animal experiments. In the longer term, well-defined human neurons produced in vitro may also serve in cell replacement strategies to restore function after neuronal loss or injury.
A remaining challenge is that many experimental conditions produced mixed populations of neuron types. The team is now focused on protocol optimization to generate pure cultures, where a single defined condition yields one specific neuron subtype reproducibly. Early results suggest that adjusting the timing of morphogen exposure and transcription factor induction can increase uniformity and make iN subtypes more similar to primary human neurons.
About this neuroscience research news
Author: Marianne Lucien
Source: ETH Zurich
Contact: Marianne Lucien – ETH Zurich
Image credit: Neuroscience News
Original Research: Closed access. “Human neuron subtype programming via single-cell transcriptome-coupled patterning screens” by Barbara Treutlein et al., published in Science. DOI: 10.1126/science.adn6121
Abstract
Human neuron subtype programming via single-cell transcriptome-coupled patterning screens
INTRODUCTION
Human excitatory and inhibitory neurons can be induced from pluripotent stem cells in vitro by forced expression of pioneer transcription factors. These induced neurons are extensively used to study neural development, differentiation, and neurological diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Programmed neurons also hold promise for cell replacement therapies. Systematic strategies that broaden the diversity of neuron types are essential for future progress.
RATIONALE
The authors hypothesized that broadly expressed pro-neural transcription factors (for example NGN2 and ASCL1), when combined with morphogen patterning signals, can direct regional identities across the central and peripheral nervous systems and thereby generate a wider array of neuron subtypes from pluripotent stem cells.
RESULTS
A systematic morphogen screening approach was used to test how different morphogen combinations interact with pro-neural transcription factors. High-throughput single-cell RNA sequencing analyzed nearly 700,000 cells across 480 unique morphogen conditions. The experiments produced diverse induced neuron subtypes resembling those in the human body, spanning forebrain, midbrain, hindbrain, spinal cord, and peripheral nervous system lineages. Many iNs shared molecular and electrophysiological features with neurons that produce glutamate, GABA, dopamine, and acetylcholine. Gene regulatory network analysis identified transcription factor regulons activated by morphogen combinations that steer cells into specific subtypes; genetic perturbations confirmed these regulons are necessary and, in some cases, sufficient for subtype specification.
CONCLUSION
The study expanded the diversity of human induced neurons generated in vitro and clarified how cooperative signaling guides cell fate decisions. Identified regulons will support targeted generation of pure cultures of specific neuron types. The morphogen-to-fate dataset is well suited for predictive modeling of cell fate outcomes, and the general approach can be applied to expand diversity in other cell types, advancing understanding of human biology, disease mechanisms, and therapeutic development.